Changes in Plasma IL-6, Plasma VEGF and Serum YKL-40 During Treatment with Etanercept and Methotrexate or Etanercept Alone in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy

Changes in plasma IL-6, plasma VEGF and serum YKL-40 were determined in rheumatoid arthritis (RA) patients during treatment with etanercept alone or in combination with methotrexate. Twenty-five patients with active RA (DAS28 ≥ 3.2) were randomized to receive etanercept (25 mg sc. biweekly) plus met...

Descripción completa

Detalles Bibliográficos
Autores principales: Knudsen, Lene Surland, Hetland, Merete Lund, Johansen, Julia Sidenius, Skjødt, Henrik, Peters, Niels Daugaard, Colic, Ada, Grau, Karin, Nielsen, Hans Jørgen, Østergaard, Mikkel
Formato: Texto
Lenguaje:English
Publicado: Libertas Academica 2009
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2796864/
https://www.ncbi.nlm.nih.gov/pubmed/20029652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2796864/
https://www.ncbi.nlm.nih.gov/pubmed/20029652

Ejemplares similares